Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

Syndax Pharmaceuticals demonstrates strong commercial momentum with Revuforj and Niktimvo, driving notable revenue growth ...

From 13th-century anchorites to the French Resistance, authors Janet Rich Edwards and Paula McLain trace the enduring power ...

The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of "Charting the Translational Pathway: ISSCR Best Practices for the Development of Pluripotent Stem Cell ...

The International Society for Stem Cell Research (ISSCR) has released "Charting the Translational Pathway: ISSCR Best Practices for the Development of Pluripotent Stem Cell (PSC)-Derived Therapies," a ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system’s coordinators, helping ...

Johnson & Johnson recently reported real-world data showing that ERLEADA® without docetaxel was associated with a ...

Xintela (XINT) announces that the company's clinical Phase I/IIa study with XSTEM® in patients with difficult-to-heal venous leg ulcers has been completed with the last follow-up visit for the last ...

Bio-Techne Corporation recently reported past second-quarter and six-month results to December 31, 2025, with sales essentially flat year-on-year at about US$295.88 million for the quarter and US$582.